Optimal duration of dual antiplatelet therapy after acute coronary syndromes and coronary stenting

Heart. 2017 Jun;103(11):871-884. doi: 10.1136/heartjnl-2015-309022. Epub 2016 Nov 25.

Authors

Alon Eisen¹, Deepak L Bhatt¹

Affiliation

¹ Brigham and Women's Hospital Heart & Vascular Center and Harvard Medical School, Boston, Massachusetts, USA.

PMID: 27888209
DOI: 10.1136/heartjnl-2015-309022

No abstract available

Publication types

Review

MeSH terms

Acute Coronary Syndrome / therapy*
Drug Administration Schedule
Humans
Percutaneous Coronary Intervention*
Platelet Aggregation Inhibitors / therapeutic use*
Stents*

Substances

Platelet Aggregation Inhibitors